capgains/lowman: Thanks for notes of meeting. Informative, nicely composed, and certainly appreciated by posters and lurkers alike.
It seems Aegis/Jones hatched elegant if not ingenious plan by suppressing complicated costly LTC IPO in favor of subsidiary swallowing parent followed by easy pie secondary offering. Not to mention folding juicy LTC $20 MM tax loss carry-forward into CSMG hybrid. Kudos to Mr. Jones and "master chefs" at Aegis.
Meanwhile, minimum 20% ownership of LTC by CSMG confirmed. Twenty percent and change arguably qualifies as significant stake in potential blockbuster surgical technology. Reducing $3.2 MM debt burden, inherited from old regime, to $775,000 is no mean feat but does argue for CSMG stake in LTC closer to 20% than outlier 33%. Additional increments, of course, would be delectable gravy.
Probable R/S hardly surprises if they have Nasdaq ambitions. Even OTC-BB stocks shine more brightly over $1.00. Proviso of no further dilution will be tested although management, top heavy with common shares, would stand to lose vis a vis non-accretive dilution.
Word that Dr. Sayari's solid sorbent TRI-PE-MCM-41 technology placed in top-two echelon is delightful news.
Thanks, again.
ctgi
These are my opinions and sentiments. Buying stocks poses demonstrable risks; you could lose all or part of your principal investment. Use iBoxes for DD start.
Buying gold won't save your soul, but it might save your skin someday.